Zaleplon and Panic attack - a phase IV clinical study of FDA data

Summary:

Panic attack is reported as a side effect among people who take Zaleplon (zaleplon), especially for people who are female, 40-49 old, also take Flomax, and have Headache.

The phase IV clinical study analyzes which people have Panic attack when taking Zaleplon. It is created by eHealthMe based on reports of 1,849 people who have side effects when taking Zaleplon from the FDA, and is updated regularly.

What is Zaleplon?

Zaleplon has active ingredients of zaleplon. It is often used in insomnia. eHealthMe is studying from 1,935 Zaleplon users. Check the latest studies of Zaleplon.

What is Panic attack?

Panic attack is found to be associated with 2,226 drugs and 2,082 conditions by eHealthMe. Check the latest studies of Panic attack.

On Jun, 25, 2026

1,849 people reported to have side effects when taking Zaleplon.
Among them, 12 people (0.65%) have Panic attack.

Among these 12 people:

What is the gender of people who have Panic attack when taking Zaleplon? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Panic attack when taking Zaleplon? *

What are other drugs people take besides Zaleplon? *

Topamax: 7 people, 58.33%
Synthroid: 7 people, 58.33%
Lyrica: 7 people, 58.33%
Flomax: 7 people, 58.33%
Lamotrigine: 3 people, 25.00%
Rizatriptan Benzoate: 3 people, 25.00%
Promethazine Hydrochloride: 3 people, 25.00%
Cyclobenzaprine Hydrochloride: 3 people, 25.00%
Carbamazepine: 3 people, 25.00%
Zolpidem Tartrate: 3 people, 25.00%

What are other side effects people have besides Panic attack? *

Gait Disturbance: 9 people, 75.00%
Malaise (a feeling of general discomfort or uneasiness): 9 people, 75.00%
Neuralgia (pain in one or more nerves): 9 people, 75.00%
Stress And Anxiety: 9 people, 75.00%
Depression: 8 people, 66.67%
Foot Fracture: 7 people, 58.33%
Loss Of Consciousness: 7 people, 58.33%
Memory Loss: 7 people, 58.33%
Musculoskeletal Discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves): 7 people, 58.33%
Nervousness: 7 people, 58.33%

What are the existing conditions these people have? *

Spinal Cord Trauma: 7 people, 58.33%
Pain: 7 people, 58.33%
Headache (pain in head): 7 people, 58.33%
Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 16.67%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 8.33%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 1 person, 8.33%
Depression: 1 person, 8.33%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 8.33%
Apnea (temporary absence or cessation of breathing): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Zaleplon and have Panic attack?

- Check whether Panic attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zaleplon:

Zaleplon (1,935 reports)

Panic attack treatments and more:

Panic attack (65,704 reports)

Browse all side effects of Zaleplon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic attack:

Panic attack (2,226 drugs)

Browse all the conditions that are associated with Panic attack:

Panic attack (2,082 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on zaleplon (the active ingredients of Zaleplon) and Zaleplon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.